These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9545226)

  • 1. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
    Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
    Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases, processing, and thymic selection.
    Cresswell P
    Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
    [No Abstract]   [Full Text] [Related]  

  • 3. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
    Honey K; Nakagawa T; Peters C; Rudensky A
    J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
    Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
    J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
    Nakagawa TY; Rudensky AY
    Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
    Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
    Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
    Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
    Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus.
    Bowlus CL; Ahn J; Chu T; Gruen JR
    Cell Immunol; 1999 Sep; 196(2):80-6. PubMed ID: 10527559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal cysteine proteases and antigen presentation.
    Rudensky A; Beers C
    Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived cells fail to induce positive selection in thymus reaggregation cultures.
    Ernst BB; Surh CD; Sprent J
    J Exp Med; 1996 Mar; 183(3):1235-40. PubMed ID: 8642265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
    Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
    J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
    Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
    J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
    Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
    Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
    Jang MH; Seth NP; Wucherpfennig KW
    J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
    Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
    Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development.
    Rodrigues PM; Sousa LG; Perrod C; Maceiras AR; Ferreirinha P; Pombinho R; Romera-Cárdenas G; Gomez-Lazaro M; Senkara M; Pistolic J; Cabanes D; Klein L; Saftig P; Alves NL
    Autophagy; 2023 Feb; 19(2):426-439. PubMed ID: 35535798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD4 T cell-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (CtsI) gene.
    Benavides F; Venables A; Poetschke Klug H; Glasscock E; Rudensky A; Gómez M; Martin Palenzuela N; Guénet JL; Richie ER; Conti CJ
    Immunogenetics; 2001 Apr; 53(3):233-42. PubMed ID: 11398968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.